SBIR-STTR Award

Developing A Clo2 Compliance Service: Minimizing Water Borne Microbial Infection
Award last edited on: 2/1/12

Sponsored Program
SBIR
Awarding Agency
NIH : NIEHS
Total Award Amount
$150,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Wolfgang U Spendel

Company Information

NoBull Innovation LLC (AKA: NBI)

444 East Second Street
Dayton, OH 45402
   (888) 678-6212
   todd@thetechpark.com
   www.nobullinnovation.com
Location: Single
Congr. District: 10
County: Montgomery

Phase I

Contract Number: 1R43ES020083-01
Start Date: 9/14/11    Completed: 8/31/12
Phase I year
2011
Phase I Amount
$150,000
The US Center for Disease Control (CDC) estimates that more than 1.7 million healthcare associated infections (HAI) are acquired in US hospitals every year, resulting in approximately 100,000 deaths and adding $30-40 billion of direct treatment expense to the nation's healthcare costs (1). Microbial pathogens from tap water are a significant source of HAI (2). Chlorine dioxide (ClO2) (CD) is a chemical disinfectant used to treat public drinking water supplies, primarily by municipal drinking water utilities. On-site, systemic application of CD, a relatively recent practice, has proven uniquely effective for controlling waterborne pathogens in healthcare facilities (3).CD treatment of institutional water is covered by the same rules that apply to municipal drinking water treatment systems;Federal regulatory requirements include daily monitoring of CD and its by-product, chlorite ion (ClO2-) (CI) (4). In order to comply with regulations, water samples are collected manually from taps at specified locations and transported to a centralized location for chemical analysis. The overall objective of the project is an integrated, fully automated, hardened system (System) that can perform all monitoring, recordkeeping and reporting functions required by US government regulations covering CD treatment of domestic water supplies. Principle components of the System are: (1) automated water sampling &flow control, (2) analytics, and (3) data management. Water sampling &flow control will incorporate recent advancements in Flow Injection Analysis (FIA), a rigorous methodology characterized by automated handling of sample and reagent solutions with strict control of reaction conditions (5). Analytics will include a proprietary electrochemical device (EC Probe) that is enabled by the research team's seminal innovations in solid-phase electrolytes and sol-gel process technology. This Phase I SBIR proposal (Proposal) has three Specific Aims: (1) optimize the EC Probe and flow system for long-term use under intended conditions;(2) design, build and test an integrated, fully-automated System;and (3) develop performance data that will demonstrate the value of engineering and cost-effective production of a standardized, commercial system in future phases.

Public Health Relevance:
CDC estimates that over 1.7 million infections per year are acquired by patients while they are in US hospitals. These healthcare associated infections (HAI) many of them caused by microbial pathogens from tap water result in nearly 100,000 deaths, an estimated $30-40 billion in direct treatment costs alone. are a significant, documented source of HAI. Upon completion, of this project the developed system-enabled compliance services would allow US healthcare institutions to implement Chlorine Dioxide water treatment, thereby substantially eliminating an entire class of HAI and saving tens of thousands of lives and billions of dollars per year.

Thesaurus Terms:
Agreement;Cdc;Centers For Disease Control;Centers For Disease Control And Prevention;Centers For Disease Control And Prevention (U.S.);Cessation Of Life;Chemicals;Chromatography;Chromatography / Separation Science;Communication;Data;Death;Devices;Disinfectants;Disinfection;Electrolytes;Engineering;Environment;Flow Injection Analyses;Flow Injection Analysis;Future;Gel;Government Regulations;Health Care Costs;Health Costs;Health Facilities;Health Care Facility;Healthcare;Healthcare Costs;Healthcare Facility;Hospitals;Hydrogen Oxide;Infection;Institution;Ions;Loinc Axis 4 System;Location;Mechanics;Method Loinc Axis 6;Methodology;Methods;Monitor;Patients;Performance;Phase;Procedures;Process;Production;Reaction;Reagent;Regulation;Reporting;Research;Residual;Residual State;Sbir;Sbirs (R43/44);Sampling;Seminal;Sensitivity And Specificity;Services;Site;Small Business Innovation Research;Small Business Innovation Research Grant;Solid;Solutions;Source;Specific Qualifier Value;Specified;System;Technology;Testing;Time;Treatment Cost;United States Centers For Disease Control;United States Centers For Disease Control And Prevention;Water;Water Supply;Work;Analytical Method;Authority;Chlorine Dioxide;Chlorine Oxide (Clo2);Chlorite;Computerized Data Processing;Cost Effective;Cost-Effective;Data Management;Data Processing;Design;Designing;Drinking Water;Health Care;Innovate;Innovation;Innovative;Mechanical;Meetings;Microbial;Pathogen;Programs;Public Drinking;Signal Processing;Treatment Program;Water Flow;Water Sampling;Water Treatment;Water-Born Infection;Water-Borne Infection;Waterborn Infection;Waterborne;Waterborne Infection

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----